Efficacy and Safety of Fenofibrate Added on to Atorvastatin Compared With Atorvastatin

A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 476 participants.

Also called NCT01956201

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 476 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT01956201
Start date
(registry gives no type) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
South Korea (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT01956201. Randomized; double masking; primary purpose treatment. Start 2013-12 (registry gives no type); primary completion 2016-08 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Efficacy and Safety of Fenofibrate Added on to Atorvastatin Compared With Atorvastatin
Condition
Mixed Hyperlipidemia
Intervention (Drug)
Atorvastatin 20mg
Intervention (Drug)
Fenofibrate 160mg
Intervention (Other)
Placebo (Fenofibrate 160 mg)
Lead sponsor
Chong Kun Dang Pharmaceutical (class: industry)

Record details

Record id
cardio:ct-nct01956201
Content hash
613317b2cb75a832bc689e51f8414cc826b2ed273696ab404b718c10ef174442